Characteristics of dual drug benefit use among veterans with dementia enrolled in the Veterans Health Administration and Medicare Part D-Reference-Cited by-同舟云学术

Characteristics of dual drug benefit use among veterans with dementia enrolled in the Veterans Health Administration and Medicare Part D

Published:2019-06 Issue:6 Volume:15 Page:701-709
ISSN:1551-7411
Container-title:Research in Social and Administrative Pharmacy
language:en
Short-container-title:Research in Social and Administrative Pharmacy

Author:

Schleiden Loren J.^ORCID,Thorpe Carolyn T.,Cashy John P.,Gellad Walid F.,Good Chester B.,Hanlon Joseph T.,Mor Maria K.^ORCID,Niznik Joshua D.,Pleis John R.,Van Houtven Courtney H.,Thorpe Joshua M.

Funder

Health Services Research and Development

Investigator Initiated Research (IIR

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacy

Reference53 articles.

1. Comparison of Quality of Care in VA and Non-VA Settings;Shekelle,2010

2. Veterans' pharmacy and health care utilization following implementation of the Medicare Part D pharmacy benefit;Stroupe;Med Care Res Rev,2017

3. Dual health care system use and high-risk prescribing in patients with dementia: a national cohort study;Thorpe;Ann Intern Med,2017

4. Impact of dual use of Department of Veterans Affairs and Medicare Part D Drug benefits on potentially unsafe opioid use;Gellad;Am J Publ Health,2018

5. Effect of dual use of Veterans Affairs (VA) and Medicare Part D drug benefits on antihypertensive refill adherence in a national cohort of Veterans with dementia;Thorpe;Health Serv Res,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caregiver and provider perspectives on dual VA and Medicare Part D medication use in veterans with suspected dementia or cognitive impairment;American Journal of Health-System Pharmacy;2021-08-28

2. Association Between Opioid Dose Reduction Against Patients’ Wishes and Change in Pain Severity;Journal of General Internal Medicine;2020-11-03

3. Misalignment of Stakeholder Incentives in the Opioid Crisis;International Journal of Environmental Research and Public Health;2020-10-16

4. An Evaluation of Statin Use Among Patients with Type 2 Diabetes at High Risk of Cardiovascular Events Across Multiple Health Care Systems;Journal of Managed Care & Specialty Pharmacy;2020-09